Diane Hershock
Incyte Corporation
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Diane Hershock as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:23 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04586244 · An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial CarcinomaIncyte Corporation · terminated · Urothelial Carcinoma · study director
- Ph1NCT03522142 · A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced MalignanciesIncyte Corporation · terminated · Advanced Solid Tumors · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:23 UTC. The ranking covers the 200 most relevant of 9 PubMed records, and a shared surname and initials can bring in a namesake. All 9 on PubMed
- Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.N Engl J Med · 20071,272 citationsRCR 32.7
- Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial.J Clin Oncol · 2002170 citationsRCR 5.4
- Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).Int J Radiat Oncol Biol Phys · 200782 citationsRCR 2.1
- A phase I study of SPI-077 (Stealth liposomal cisplatin) concurrent with radiation therapy for locally advanced head and neck cancer.Invest New Drugs · 200242 citationsRCR 1.0
- Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neck.Int J Radiat Oncol Biol Phys · 201520 citationsRCR 0.7
- Pilot study of organ preservation multimodality therapy for locally advanced resectable oropharyngeal carcinoma.Am J Clin Oncol · 200013 citationsRCR 0.4
- Final report of a pilot trial of accelerated radiotherapy plus concurrent 96-hour infusional paclitaxel for locally advanced head and neck cancer.Am J Clin Oncol · 200411 citationsRCR 0.3
- 8 citationsRCR 0.2
- Pharmacokinetics and excretion of (14)C-omacetaxine in patients with advanced solid tumors.Invest New Drugs · 20163 citationsRCR 0.1